Premium
Effects of Betamethasone Treatment on Central Myelination in Fetal Sheep: An Electron Microscopical Study
Author(s) -
Raschke C.,
Schmidt S.,
Schwab M.,
Jirikowski G.
Publication year - 2008
Publication title -
anatomia, histologia, embryologia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.34
H-Index - 35
eISSN - 1439-0264
pISSN - 0340-2096
DOI - 10.1111/j.1439-0264.2007.00807.x
Subject(s) - corpus callosum , white matter , myelin , anatomy , commissure , betamethasone , axon , biology , neuroscience , pathology , central nervous system , medicine , endocrinology , magnetic resonance imaging , radiology
Summary The long‐term effect of betamethasone on the myelination of commissural and associational fibres was investigated in fetal sheep. We studied the corpus callosum and subcortical white matter by electron microscopy. Axons were subdivided into classes according to their axonal diameter: class I: ≤0.65 μm; class II: 0.66–0.84 μm; class III: ≥0.85 μm. Under control conditions, the different functions of the white matter tracts examined were reflected by three morphological criteria: (1) there was a diverse percentage of axonal classes in the investigated areas. In corpus callosum the axons of class II predominate (47.1%). In the subcortical white matter, class I axons with small diameter are in majority (40.8%). (2) In the subcortical white matter more axons are present, with especially large diameter and hence of axonal class III. (3) The axons of subcortical white matter have thicker myelin sheaths than those of the corpus callosum. Betamethasone administration caused a significant decrease of class II axons in the corpus callosum (36.9%). In corpus callosum, axons of all classes present thicker myelin sheaths. Betamethasone administration resulted in a change in the formation of the myelin sheath in the commissural fibres of the corpus callosum but not in the associational fibres of the subcortical white matter. This could be the morphological correlate to behavioral and cognitive changes known to occur in humans after prenatal glucocorticoid treatment.